Clinical Trials Logo

Clinical Trial Summary

The aims of this study were to identify risk factors associated with delirium in hospitalized persons with dementia, and to describe immediate and post-hospital (1&3 months) trajectory of cognitive decline and associated outcomes in persons with dementia who develop delirium. It was hypothesized that factors such as CNS-active medications, urinary tract infection, stage of dementia, pain, activity level, and dehydration would be associated with an increased risk of delirium and delirium severity in patients with dementia compared to dementia patients without delirium. It was also hypothesized that persons with DSD will have worse outcomes (longer hospital length of stays, decreased functional status, a steeper negative slope of cognitive decline) than dementia patients without delirium. Lastly, it was hypothesized that higher delirium severity would be associated with poorer outcomes in persons with dementia. The long-term objectives were to use the results from this study to design and test an intervention strategy to improve early recognition, management, prevention, and outcomes in persons with DSD.


Clinical Trial Description

It is well known that persons with dementia are at increased risk of developing delirium or acute confusional state. Further, current evidence suggests that delirium may worsen the prognosis of dementia, may alter the clinical course and trajectory of cognitive decline, and may be associated with substantially worse long-term outcomes. This study was a prospective cohort study design involving 165 hospitalized subjects with dementia who were 65 and older and included a three month follow up period. Aims for the study included: 1) to identify risk factors for DSD, and 2) to describe post-hospital outcomes and the trajectory of cognitive decline for DSD, which will justify the development of appropriate preventative and management strategies for delirium in patients with dementia. Delirium was assessed daily from admission to discharge and then at one and three month follow-ups. The potential risk factors being examined were 1) polypharmacy (central nervous system-active medications, number of medications, new medications added), 2) physical stressors (urinary tract infection, pain, dehydration), and 3) environmental stressors (bedrest, restraints, room changes). Outcomes were assessed by research study staff blinded to the study aims. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01394328
Study type Observational
Source Penn State University
Contact
Status Completed
Phase N/A
Start date April 2006
Completion date November 2008

See also
  Status Clinical Trial Phase
Recruiting NCT05391334 - Early Fall Risk Detection and Fall Prevention Among Inpatients With Delirium
Terminated NCT03941119 - Evaluating the Impact of VR-therapy on BPSD and QoL of Individuals With Dementia Admitted to Hospital N/A
Completed NCT05398211 - Music Therapy as a Treatment for Delirium in Acutely Hospitalized Older Patients N/A
Recruiting NCT05630014 - Study of the Aliviado DSD Caregiving Mastery Program N/A
Active, not recruiting NCT06176625 - Sight and Hearing Investigation Into Effects on Delirium N/A
Recruiting NCT04973709 - Prevalence of Dementia and Delirium in Outpatient Clinics (DESTAN Trial)
Recruiting NCT05915377 - Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
Completed NCT01505257 - Early Nurse Detection and Management of Delirium N/A